UMDF, MitoAction Help Lift Up Patient Voices on FDA Listening Session for Pyruvate Dehydrogenase Complex Deficiency (PDCD)

The United Mitochondrial Disease Foundation and MitoAction share their reactions to a September 8, 2023 listening session with the U.S. Food and Drug Administration regarding Pyruvate Dehydrogenase Complex Deficiency (PDCD). PITTSBURGH, Sept. 15, 2023 /PRNewswire-PRWeb/ -- Today, patient...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: FDA NPT Source Type: news